Bargains! PROMOTIONS

Close Notification

Your cart does not contain any items

$185.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Churchill Livingstone
28 December 2025
Rare and Orphan Lung Diseases, An Issue of Clinics in Chest Medicine
Edited by:   , , , , ,
Imprint:   Churchill Livingstone
Country of Publication:   United Kingdom
Dimensions:   Height: 254mm,  Width: 178mm, 
Weight:   450g
ISBN:   9780443317347
ISBN 10:   0443317348
Series:   The Clinics: Internal Medicine
Pages:   240
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active
Current Perspectives on The Diagnosis and Management of Lymphangioleiomyomatosis Pulmonary Langerhans Cell Histiocytosis Birt-Hogg-Dube“ Syndrome Pulmonary Alveolar Proteinosis Pulmonary Alveolar Microlithiasis: A Disorder of Pulmonary Phosphate Homeostasis Eosinophilic Lung Diseases Genetic Familial Interstitial Lung Disease Hermansky-Pudlak Syndrome Amyloid and Light Chain Deposition Disorders Neuroendocrine Hyperplasia of Infancy and Diffuse Idiopathic Neuroendocrine Cell Hyperplasia: Two Faces of Pulmonary Neuroendocrine Cell Pathology Pulmonary Manifestations of Lysosomal Storage Disorders in Adults

Prior to being appointed in 2018 as Associate Professor of Medicine in UCD and Consultant Respiratory Physician at St. Vincent's Hospital Group Associate Professor of Medicine in UCD, Cormac McCarthy was the Rare Lung Disease Scholar at the Rare Lung Disease Consortium in the United States, based in Cincinnati, Ohio. He is a graduate of the Royal College of Surgeons in Ireland (RCSI), obtaining an Honours degree in Medicine in 2007. He completed higher specialist training through the Royal College of Physician of Ireland (RCPI) and was awarded a Certificate of Satisfactory Completion of Specialist Training by the Irish Committee on Higher Specialist Training (Respiratory and General Internal Medicine) in 2017. He continued post-graduate training at the University of Cincinnati Medical Center and Cincinnati Children's Hospital, where he completed an ACGME-accredited Clinical Fellowship in Genetic Pulmonary Disease, and he continued his training there as a Rare Lung Disease Scholar where he conducted research, resulting in many high impact publications. His primary research areas were on the molecular mechanisms of lung disease, utilizing pathogenesis approach to develop new therapies. He continues to have a strong interest in all lung diseases, with a particular focus on interstitial lung disease, rare lung disease, cystic lung disease syndromes and obstructive airway disorders.

See Also